Wenyue Zhang
Overview
Explore the profile of Wenyue Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang Y, Jiang H, Zou Y, Wang Z, Gan T, Zeng R, et al.
Int Immunopharmacol
. 2025 Mar;
152:114447.
PMID: 40088869
Mycobacterial infection poses a significant threat to human health, with granuloma formation serving as a hallmark pathological feature and a critical diagnostic indicator. Langhans giant cells (LGCs) play a pivotal...
2.
Wen S, Chang S, Zhang H, Zhang W, Guo Y, Zhang N, et al.
Toxicol Appl Pharmacol
. 2025 Mar;
:117294.
PMID: 40057001
No abstract available.
3.
Xu H, Yin L, Zou L, Zhang E, Cheng Y, Zhang W, et al.
Int Immunopharmacol
. 2025 Mar;
152:114427.
PMID: 40056513
Background: The mechanisms underlying Rheumatoid Arthritis (RA) remain unclear. Despite having relatively well-defined treatment strategies, current therapeutic approaches only achieve a remission rate of 70 %-80 %, with poor prognosis...
4.
Liu P, Li Y, Li H, Zhang W, Qi Y, Zhang X, et al.
Sci Rep
. 2025 Mar;
15(1):7380.
PMID: 40025216
In this study, a severely damaged official document produced in the Qing Dynasty (1911 A.D.), was characterized using a range of techniques and subsequently restored using the traditional Chinese conservation...
5.
Qiao L, Zhang M, Jiang H, Shi Y, Zhang W, Mei Y, et al.
BMC Public Health
. 2025 Feb;
25(1):798.
PMID: 40016681
Background: With the prevalence of leprosy dramatically declining, the focus of leprosy control has gradually shifted from the implementation of multidrug therapy (MDT) to accelerating the reduction of the disease...
6.
Liu X, Zhang W, Zhang L, Li L, Han Y, Ali M, et al.
Int Ophthalmol
. 2025 Feb;
45(1):72.
PMID: 39934451
Purpose: To evaluate the efficiency and safety profiles of a technique of simultaneous reconstruction of traumatic lacrimal duct obstruction and medial canthus deformity using micro-anchors. Methods: A retrospective interventional study...
7.
Liu S, Yan W, Zhang W, Zhang J, Li Z, Guo Y, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2412067.
PMID: 39928524
Cuproptosis is a newly discovered copper-dependent form of cell death. Intracellular glutathione (GSH) acts as a copper chelator to inhibit cuproptosis, so the reduction of GSH concentration is conducive to...
8.
Wang X, Xiang Z, Zhang Y, Tu C, Huang C, Chung Y, et al.
MedComm (2020)
. 2025 Feb;
6(2):e70078.
PMID: 39901895
Interleukin (IL)-17-producing γδ-T cells (γδT-17) are a major source of IL-17 within the tumor microenvironment and have been shown to influence tumor development and therapy outcomes in various cancers. However,...
9.
Gao Y, Liu J, Wu M, Zhang Y, Wang M, Lyu Q, et al.
ACS Nano
. 2025 Jan;
19(4):4251-4268.
PMID: 39862206
Melanoma is the most aggressive type of skin cancers. Traditional chemotherapy and radiotherapy have limited effectiveness and can lead to systemic side effects. Photodynamic therapy (PDT) is a photoresponsive cancer...
10.
Wen S, Chang S, Zhang H, Zhang W, Guo Y, Zhang N, et al.
Toxicol Appl Pharmacol
. 2025 Jan;
495:117236.
PMID: 39855310
Background: Silicosis is a lung disease caused by the inhalation of free crystalline silica and is characterized mainly by lung inflammation and progressive pulmonary fibrosis. Shikonin, a biologically active compound...